Skip to main content
Eli Ipp, MD, Endocrinology, Torrance, CA

Eli Ipp MD

Diabetes, Lipid Metabolism


Professor of Medicine, UCLA

Join to View Full Profile
  • 21840 Normandie AveSte 700Torrance, CA 90502

  • Phone+1 310-222-5101

  • Fax+1 310-320-5463

Dr. Ipp is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Eli Ipp is an endocrinologist based in Torrance, CA, with subspecialties in diabetes and lipid metabolism. He graduated from the University of the Witwatersrand in 1968. Dr. Ipp's research contributions include several publications on diabetes pathophysiology and genetic association studies, notably in prestigious journals such as Nature and Communications Biology. His work has been cited multiple times, indicating engagement with the scientific community. He has been recognized as a "Super Doctor" by SuperDoctors.com.

Education & Training

  • University of the Witwatersrand
    University of the WitwatersrandClass of 1968

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1985 - 2026
  • IL State Medical License
    IL State Medical License 1980 - 1987
  • TX State Medical License
    TX State Medical License 1977 - 1985
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Endocrinology, Diabetes and Metabolism
    American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • Super Doctor SuperDoctors.com

Publications & Presentations

PubMed

Press Mentions

  • Researchers Study Improvement in Patient Compliance and Screening Efficacy by Using the EyeArt AI Eye Screening System for Detecting Diabetic Retinopathy
    Researchers Study Improvement in Patient Compliance and Screening Efficacy by Using the EyeArt AI Eye Screening System for Detecting Diabetic RetinopathyJune 5th, 2019
  • Robocalls Improve Diabetes Eye Screening Among Low-Income Minorities
    Robocalls Improve Diabetes Eye Screening Among Low-Income MinoritiesMarch 17th, 2018

Grant Support

  • Genetics Of Diabetic Retinopathy In HispanicsNational Center For Research Resources2008–2010
  • Beta Cell Compensatory Factors In Insulin ResistanceNational Center For Research Resources2008–2010
  • Transplantation Alone (ITA) In Patients With Difficult Control Type I DiabeteNational Center For Research Resources2005–2010
  • Insulinopenic Type 2 Diabetes In HispanicsNational Center For Research Resources2005–2010
  • Evaluation And Mechanisms In Insulin Secreting TumorsNational Center For Research Resources2004–2010

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: